Advanced Biomedical Research
Common antigens between hydatid cyst and cancers
Authors
- Shima Daneshpour 1
- Mehran Bahadoran 2
- Seyed Hossein Hejazi 2
- Abas Ali Eskandarian 2
- Mehdi Mahmoudzadeh 3
- Hossein Yousofi Darani 2
1 Department of Parasitology and Mycology, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Parasitology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
3 Department of Internal Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract
Background: Different research groups reported a negative correlation between cancers and parasitical infections. As an example, the prevalence of a hydatid cyst among patients with cancer was significantly lower than its prevalence among normal population. Tn antigens exist both in cancer and hydatid cyst. This common antigen may be involved in the effect of parasite on cancer growth. So in this work, common antigens between hydatid cyst and cancers have been investigated.
Materials and Methods: Different hydatid cyst antigens including hydatid fluid, laminated and germinal layer antigens, and excretory secretory antigens of protoscolices were run in SDS PAGE and transferred to NCP paper. In western immunoblotting, those antigens were probed with sera of patients with different cancer and also sera of non-cancer patients. Also, cross reaction among excretory secretory products of cancer cells and antisera raised against different hydatid cyst antigen was investigated.
Results: In western immunoblotting, antisera raised against laminated and germinal layers of hydatid cyst reacted with excretory secretory products of cancer cells. Also, a reaction was detected between hydatid cyst antigens and sera of patients with some cancers.
Conclusion: Results of this work emphasize existence of common antigens between hydatid cyst and cancers. More investigation about these common antigens is recommended.
Keywords
| 1. |
Akgül H, Tez M, Ünal AE, Keskek M, Sayek I, Özçelik T. Echinococcus against cancer: Why not? Cancer 2003;98:1999-2000.  |
| 2. |
Plumelle Y, Gonin C, Edouard A, Bucher BJ, Thomas L, Brebion A, et al. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol 1997;107:81-7. |
| 3. |
Yousofi Darani H, Yousefi M. Parasites and cancers: Parasite antigens as possible targets for cancer immunotherapy. Future Oncol 2012;8:7. |
| 4. |
Batmonkh Z, Kallinikova VD, Pakhorukova LV, Kravtsov EG, Karpenko LP, Dalin MV. In vivo anticancer activity of lysates from trypanosoma cruzi of different genetic groups. Bull Exp Biol Med 2006;142:470-3. |
| 5. |
Kallinikova VD, Batmonkh T, Kosobokova EN, Pakhorukova LV, Ogloblina TA, Kravtsov EG, et al. Antibodies against Trypanosoma cruzi in intact mice and their oncoprotective effect. Med Parazitol (Mosk) 2008;1:11-5. |
| 6. |
Kallinikova VD, Borisova EN, Pakhorukova LV, Ogloblina TA, Batmonkh Ts, Kravtsov EG, et al. Immunization against Trypanosoma cruzi and tumor growth in mice. Med Parazitol (Mosk) 2006;4:9-12. |
| 7. |
Kallinikova VD, Matekin PV, Ogloblina TA, Leĭkina MI, Kononenko AF, Sokolova NM, et al. Anticancer properties of flagellate protozoan Trypanosoma cruzi Chagas, 1909. Izv Akad Nauk Ser Biol 2001;3:299-311. |
| 8. |
Kinnamon KE, Poon BT, Hanson WL, Waits VB. Activity of anticancer compounds against Trypanosoma cruzi-infected mice. Am J Trop Med Hyg 1998;58:804-6. |
| 9. |
Sheklakova LA, Kallinikova VD, Karpenko LP. Genetic heterogeneity of Trypanosoma cruzi and its direct anticancer effect in cultured human tumor cells. Bull Exp Biol Med 2003;135:89-92. |
| 10. |
Zenina AV, Kravtsov EG, Tsetsegsaikhan B, Yashina NV, Dalin MV, Karpenko LP, et al. The study of immunological component in antitumor effect of Trypanosoma cruzi. Bull Exp Biol Med 2008;145:352-4. |
| 11. |
Choo JD, Lee JS, Kang JS, Lee HS, Yeom JY, Lee YH. Inhibitory effects of toxoplasma antigen on proliferation and invasion of human glioma cells. J Korean Neurosurg Soc 2005;37:129-36. |
| 12. |
Hibbs JB Jr, Lambert LH, Remington JS. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. J Infect Dis 1971;124:587-92. |
| 13. |
Kim JO, Jung SS, Kim SY, Kim TY, Shin DW, Lee JH, et al. Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis. J Korean Med Sci 2007;22:S38-46. |
| 14. |
Miyahara K, Honda U, Tose S, Sakurai H, Igarashi I, Saito A, et al. Therapeutic effects of Toxoplasma lysate antigen on 20-methylcholanthrene-induced BALB/c mouse tumors. J Vet Med Sci 1992;54:7-12. |
| 15. |
Miyahara K, Yokoo N, Sakurai H, Igarashi I, Sakata Y, Yoshida Y, et al. Antitumor activity of Toxoplasma lysate antigen against methylcholanthrene-induced tumor-bearing rats. J Vet Med Sci 1992;54:221-8. |
| 16. |
Pyo KH, Jung BK, Chai JY, Shin EH. Suppressed CD31 Expression in Sarcoma-180 Tumors after Injection with Toxoplasma gondii Lysate Antigen in BALB/c Mice. Korean J Parasitol 2010;48:171-4. |
| 17. |
Suzuki Y, Kobayashi A. Antitumor effect of intralesional injection with formalin-fixed Toxoplasma gondii organisms on Lewis lung carcinoma in Toxoplasma-infected mice. Cancer Lett 1985;25:247-54. |
| 18. |
Suzuki Y, Muto M, Kobayashi A. Antitumor effect of formalin-fixed Toxoplasma gondii organisms on EL4 lymphoma in Toxoplasma-infected mice. J Biol Response Mod 1986;5:288-93. |
| 19. |
Darani HY, Shirzad H, Mansoori F, Zabardast N, Mahmoodzadeh M. Effects of Toxoplasma gondii and Toxocara canis antigens on WEHI-164 fibrosarcoma growth in a mouse model. Korean J Parasitol 2009;47:175-7. |
| 20. |
Pidherney MS, Alizadeh H, Stewart GL, McCulley JP, Niederkorn JY. In vitro and in vivo tumoricidal properties of a pathogenic/free-living amoeba. Cancer Lett 1993;72:91-8. |
| 21. |
Chen L, He Z, Qin L, Li Q, Shi X, Zhao S, et al. Antitumor effect of malaria parasite infection in a murine lewis lung cancer model through induction of innate and adaptive immunity. PloS One 2011;6:e24407. |
| 22. |
Atayde VD, Jasiulionis MG, Cortez M, Yoshida N. A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells. Melanoma Res 2008;18:172-83. |
| 23. |
Yousofi Darani H, Soozangar N, Khorami S, Taji F, Yousofi M, Shirzad H. Hydatid cyst protoscolices induce cell death in WEHI-164 fibrosarcomacells and inhibit the proliferation of baby hamster kidney fibroblasts in vitro. J Parasitol Res 2012;2012:304183. |
| 24. |
Shirzad H, Khorami S, Soozangar N, Yousefi M, Darani HY. Toxoplasma gondii but not Leishmania major orTrichomonas vaginalis decreases cell proliferation and increases cell death on fibrosarcoma cancer cells in culture medium. World J Vaccine 2012;2:105-8. |
| 25. |
Alvarez Errico D, Medeiros A, Míguez M, Casaravilla C, Malgor R, Carmona C, et al. O-glycosylation in Echinococcus granulosus: Identification and characterization of the carcinoma-associated Tn antigen. Exp Parasitol 2001;98:100-9. |
| 26. |
Nyame K, Cummings R and Damian R. Schistosoma mansoni synthesizes glycoproteins containing terminal O-linked N-acetylglucosamine residues. J Biol Chem 1987;262:7990-5. |
| 27. |
Baldus SE, Engelmann K, Hanisch FG. MUC1 and the MUCs: A family of human mucins with impact in cancer biology. Crit Rev Clin Lab Sci 2004;41:189-231. |
| 28. |
Thomas PG, Harn Jr DA. Immune biasing by helminth glycans. Cell Microbiol 2004;6:13-22. |
| 29. |
Ubillos L, Medeiros A, Cancela M, Casaravilla C, Saldaña J, Domínguez L, et al. Characterization of the carcinoma-associated Tk antigen in helminth parasites. Exp Parasitol 2007;116:129-36. |
| 30. |
Casaravilla C, Freire T, Malgor R, Medeiros A, Osinaga E, Carmona C. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: Evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferase activity. J Parasitol 2003;89:709-14. |
| 31. |
Freire T, Casaravilla C, Carmona C, Osinaga E. Mucin-type O-glycosylation in Fasciola hepatica: Characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferase activity. Int J Parasitol 2003;33:47-56. |
| 32. |
Thors C, Jansson B, Helin H, Linder E. Thomsen-Friedenreich oncofetal antigen in Schistosoma mansoni: Localization and immunogenicity in experimental mouse infection. Parasitology 2006;132:73-81. |
| 33. |
Livingston PO, Zhang S, Lloyd KO. Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale. Cancer Immunol Immunother 1997;45:1-9. |
| 34. |
Slovin SF, Keding SJ, Ragupathi G. Carbohydrate vaccines as immunotherapy for cancer. Immunol Cell Boils 2005;83:418-28. |
| 35. |
Darani HY, Yousefi M. Parasites and cancers: Parasite antigens as possible targets for cancer immunotherapy. Future Oncol 2012;8:1529-35. |
| 36. |
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5. |
| 37. |
Dar FK, Buhidma MA, Kidwai SA. Hydatid false positive serological test results in malignancy. Br Med J (Clin Res Ed) 1984;288:1197-7. |
| 38. |
Pfister M, Gottstein B, Cerny T, Cerny A. Immunodiagnosis of echinococcosis in cancer patients. Clin Microbiol Infect 2008;5:693-7.
|
)